CGON insider buying and SEC filings, explained
CG Oncology, Inc. · CIK 1991792
Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov
Insider activity in the last 12 months
Bought
$0
Insiders who bought
0
Sold (not marked 10b5-1)
$0
Planned sales (10b5-1)
$4.8M
Insider purchases and sales, last 12 months
| Traded | Type | What was filed | Source |
|---|---|---|---|
| Oct 15, 2026 | Planned (10b5-1) | Leonard E. Post (Director) sold 1,000 shares at about $62.07 ($62K), marked as a 10b5-1 plan trade. Holdings down 100% to 0 shares. | SEC filing Filed Oct 19, 2026, 4:30 PM ET |
| Sep 15, 2026 | Planned (10b5-1) | Leonard E. Post (Director) sold 1,000 shares at about $72.98 ($73K), marked as a 10b5-1 plan trade. Holdings down 100% to 0 shares. | SEC filing Filed Sep 17, 2026 |
| Aug 14, 2026 | Planned (10b5-1) | Leonard E. Post (Director) sold 1,000 shares at $74.54 ($75K), marked as a 10b5-1 plan trade. Holdings down 100% to 0 shares. | SEC filing Filed Aug 18, 2026 |
| Jul 15, 2026 | Planned (10b5-1) | Leonard E. Post (Director) sold 1,000 shares at $71.17 ($71K), marked as a 10b5-1 plan trade. Holdings down 100% to 0 shares. | SEC filing Filed Jul 17, 2026 |
| Jul 10, 2026 | Planned (10b5-1) | James Mulay (Director) sold 24,165 shares at about $75.16 ($1.8M), marked as a 10b5-1 plan trade. Holdings down 100% to 0 shares. | SEC filing Filed Jul 14, 2026 |
| Jun 25, 2026 | Purchase (code P) | Brian Guan-Chyun Liu (Director) bought 371,085 shares indirectly (by entity) at $66.87 ($24.8M), reported as a purchase (code P). Holdings by entity up 24% to 1,886,236 shares. | SEC filing Filed Jun 29, 2026 |
| Jun 24, 2026 | Planned (10b5-1) | Leonard E. Post (Director) sold 5,000 shares at $70.00 ($350K), marked as a 10b5-1 plan trade. Holdings down 100% to 0 shares. | SEC filing Filed Jun 25, 2026 |
| Jun 22, 2026 | Planned (10b5-1) | Leonard E. Post (Director) sold 5,000 shares at $65.00 ($325K), marked as a 10b5-1 plan trade. Holdings down 100% to 0 shares. | SEC filing Filed Jun 23, 2026 |
| Jun 15, 2026 | Planned (10b5-1) | James Mulay (Director) sold 1,964 shares at $60.12 ($118K), marked as a 10b5-1 plan trade. Holdings down 100% to 0 shares. | SEC filing Filed Jun 16, 2026 |
| Jun 4, 2026 | Planned (10b5-1) | Leonard E. Post (Director) sold 1,000 shares at $54.50 ($55K), marked as a 10b5-1 plan trade. Holdings down 100% to 0 shares. | SEC filing Filed Jun 5, 2026 |
| Apr 17, 2026 | Planned (10b5-1) | James Mulay (Director) sold 15,600 shares at about $73.01 ($1.1M), marked as a 10b5-1 plan trade. Holdings down 100% to 0 shares. | SEC filing Filed Apr 20, 2026 |
| Mar 16, 2026 | Planned (10b5-1) | James Mulay (Director) sold 1,964 shares at $63.50 ($125K), marked as a 10b5-1 plan trade. Holdings down 100% to 0 shares. | SEC filing Filed Mar 17, 2026 |
| Jan 9, 2026 | Planned (10b5-1) | James Mulay (Director) sold 11,145 shares at about $52.47 ($585K), marked as a 10b5-1 plan trade. Holdings down 100% to 0 shares. | SEC filing Filed Jan 13, 2026 |
| Nov 17, 2025 | Planned (10b5-1) | Leonard E. Post (Director) sold 1,000 shares at $41.43 ($41K), marked as a 10b5-1 plan trade. Holdings down 100% to 0 shares. | SEC filing Filed Nov 18, 2025 |
27 routine transactions (such as grants, option exercises or tax withholding) are not listed.
Cluster buys
No cluster buys in the last 12 months.
Red flags
No red flags in the last 12 months.
Key events
No key events in the last 12 months.
8-K filings, last 12 months
No 8-K filings in the last 12 months.
Red flags are objective triggers only: the item or form filed, never an opinion.
Follow CGON in the Insider Ledger app
Get the appA plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.